MRK · Categories · Downgrades
MRK - Analyst downgrades
Merck & Company Inc. (MRK) analyst downgrades - real-time wire coverage filtered to Downgrades only.
Recent Downgrades for MRK
- Merck downgraded by Berenberg with a new price targetBerenberg downgraded Merck from Buy to Hold and set a new price target of $90.00
- Merck downgraded by Citigroup with a new price targetCitigroup downgraded Merck from Buy to Neutral and set a new price target of $84.00
- Merck downgraded by Deutsche Bank with a new price targetDeutsche Bank downgraded Merck from Buy to Hold and set a new price target of $105.00 from $128.00 previously
- Merck downgraded by TD Cowen with a new price targetTD Cowen downgraded Merck from Buy to Hold and set a new price target of $100.00 from $121.00 previously
- Merck downgraded by Truist with a new price targetTruist downgraded Merck from Buy to Hold and set a new price target of $110.00
- Merck downgraded by BMO Capital Markets with a new price targetBMO Capital Markets downgraded Merck from Outperform to Market Perform and set a new price target of $105.00 from $136.00 previously
- Merck downgraded by Daiwa SecuritiesDaiwa Securities downgraded Merck from Buy to Neutral
- Merck downgraded by Societe Generale with a new price targetSociete Generale downgraded Merck from Hold to Sell and set a new price target of $104.00
- Merck downgraded by Societe GeneraleSociete Generale downgraded Merck from Buy to Hold
- Merck downgraded by Wells Fargo with a new price targetWells Fargo downgraded Merck from Overweight to Equal Weight and set a new price target of $115.00 from $120.00 previously
- Merck downgraded by UBS with a new price targetUBS downgraded Merck from Buy to Neutral and set a new price target of $76.00 from $98.00 previously
- Merck downgraded by GuggenheimGuggenheim downgraded Merck from Buy to Neutral
- Merck & Co downgraded by Citigroup with a new price targetCitigroup downgraded Merck & Co from Buy to Neutral and set a new price target of $85.00 from $105.00 previously
- Merck & Co downgraded by Morgan Stanley with a new price targetMorgan Stanley downgraded Merck & Co from Overweight to Equal-Weight and set a new price target of $85.00 from $90.00 previously
- Merck downgraded by ArgusArgus downgraded Merck from Buy to Hold